Tango Therapeutics, Inc. Board of Directors

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company develops TNG462, an oral small molecule methylthioadenosine-cooperative inhibitor for the treatment for cancers with methylthioadenosine phosphorylase deletions; TNG260, a co-repressor of repressor element-1 silencing transcription -selective inhibitor; TNG348, an ubiquitin-specific protease 1 inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. It has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. Tango Therapeutics, Inc. was founded in 2017 and is headquartered in Boston, Massachusetts.

Dr. Barbara L. Weber M.D.

Dr. Barbara L. Weber M.D.

President, CEO & Director

Mr. Jannik N. Andersen Ph.D.

Mr. Jannik N. Andersen Ph.D.

Chief Scientific Officer

Dr. Antoni Ribas M.D., Ph.D.

Dr. Antoni Ribas M.D., Ph.D.

Founder & Member of Scientific Advisory Board

Mr. Douglas J. Barry Esq., J.D.

Mr. Douglas J. Barry Esq., J.D.

Chief Legal Officer, Chief Compliance Officer & Corporate Secretary

Mr. Timothy Redfern

Mr. Timothy Redfern

Chief Financial Officer

Dr. Michael Palmieri Ph.D.

Dr. Michael Palmieri Ph.D.

Head of Technical Operations

Ms. Julie Carretero

Ms. Julie Carretero

Chief Human Resources Officer

Dr. Adam S. Crystal M.D., Ph.D.

Dr. Adam S. Crystal M.D., Ph.D.

President of Research & Development

Dr. Alan Ashworth FRS, Ph.D.

Dr. Alan Ashworth FRS, Ph.D.

Founder & Member of Scientific Advisory Board

Dr. William G. Kaelin Jr., M.D.

Dr. William G. Kaelin Jr., M.D.

Founder & Member of Scientific Advisory Board

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.